Login | Register

Sorafenib (Nexavar) Delays Rare Thyroid Cancer By 5 Months

Sorafenib (Nexavar) stops metastatic thyroid cancer tumor growth for nearly twice as long as a placebo, researchers from Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania announced as they reported on a randomized phase III trial at the ASCO Annual Meeting in Chicago, Illinois...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *